In the BioHarmony Drug Report Database
Afstyla (lonoctocog alfa) is an unknown pharmaceutical. Lonoctocog alfa was first approved as Afstyla on 2017-01-04. It is used to treat factor VII deficiency, hemophilia a, hemorrhage, and von willebrand diseases in the USA. It has been approved in Europe to treat hemophilia a.
Image (chem structure or protein)